drugset / Trial / NCT00005120

The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00005120 ↗

Phase 1 Unknown 16 enrolled Sarawak MediChem Pharmaceuticals
Double-blindTreatment

Summary

The purpose of this study is to see if it is safe and effective to give calanolide A to HIV-infected adults who have not used anti-HIV drugs in the past.

Timeline

Start
2000-04
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Calanolide A Unknown — —